$ROKA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sorrento Tech, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sorrento Tech, Inc.. Get notifications about new insider transactions in Sorrento Tech, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.68 | 1,899 | 1,291 | 0 | 1.9 K to 0 (-100.00 %) |
Oct 05 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.68 | 199,718 | 135,808 | 0 | 199.7 K to 0 (-100.00 %) |
Oct 02 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.74 | 888 | 657 | 1,899 | 2.8 K to 1.9 K (-31.86 %) |
Oct 02 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.74 | 93,246 | 69,002 | 199,718 | 293 K to 199.7 K (-31.83 %) |
Oct 02 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.72 | 3,592 | 2,586 | 2,787 | 6.4 K to 2.8 K (-56.31 %) |
Oct 02 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.72 | 376,950 | 271,404 | 292,964 | 669.9 K to 293 K (-56.27 %) |
Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.92 | 498 | 458 | 6,379 | 6.9 K to 6.4 K (-7.24 %) |
Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.92 | 52,301 | 48,117 | 669,914 | 722.2 K to 669.9 K (-7.24 %) |
Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.03 | 706 | 727 | 6,877 | 7.6 K to 6.9 K (-9.31 %) |
Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.03 | 74,096 | 76,319 | 722,215 | 796.3 K to 722.2 K (-9.30 %) |
Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 125 | 188 | 7,583 | 7.7 K to 7.6 K (-1.62 %) |
Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 13,075 | 19,613 | 796,311 | 809.4 K to 796.3 K (-1.62 %) |
Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 10 | 15 | 7,708 | 7.7 K to 7.7 K (-0.13 %) |
Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 1,090 | 1,635 | 809,386 | 810.5 K to 809.4 K (-0.13 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 52 | 79 | 7,718 | 7.8 K to 7.7 K (-0.67 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 5,448 | 8,281 | 810,476 | 815.9 K to 810.5 K (-0.67 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.49 | 28 | 42 | 7,770 | 7.8 K to 7.8 K (-0.36 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.49 | 2,952 | 4,398 | 815,924 | 818.9 K to 815.9 K (-0.36 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 630 | 958 | 7,798 | 8.4 K to 7.8 K (-7.48 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 66,166 | 100,572 | 818,876 | 885 K to 818.9 K (-7.48 %) |
Jun 30 2017 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | A | 2.55 | 3,000 | 7,650 | 3,000 | |
Jun 30 2017 | ROKA | Roka BioScience, I ... | Cohen Fred E | Director | Option Exercise | A | 2.55 | 3,000 | 7,650 | 3,000 | |
Jun 30 2017 | ROKA | Roka BioScience, I ... | MCGIRR DAVID W J | Director | Option Exercise | A | 2.55 | 3,000 | 7,650 | 3,000 | |
Jun 30 2017 | ROKA | Roka BioScience, I ... | Doyle Michael P. | Director | Option Exercise | A | 2.55 | 3,000 | 7,650 | 3,000 | |
Jun 30 2017 | ROKA | Roka BioScience, I ... | VALERIANI NICHOLAS J | Director | Option Exercise | A | 2.55 | 3,000 | 7,650 | 3,000 | |
Mar 28 2017 | ROKA | Roka BioScience, I ... | Mary Beth Duseau | CEO and President | Option Exercise | A | 3.45 | 115,000 | 396,750 | 115,000 | |
Mar 28 2017 | ROKA | Roka BioScience, I ... | Boesgaard Lars | Vice President, CFO | Option Exercise | A | 3.45 | 54,000 | 186,300 | 54,000 | |
Feb 15 2017 | ROKA | Roka BioScience, I ... | TPG Group Holdings (SBS) Advis ... | 10% Owner | Option Exercise | C | 0.00 | 4,000 | 0 | 0 | |
Feb 15 2017 | ROKA | Roka BioScience, I ... | TPG Group Holdings (SBS) Advis ... | 10% Owner | Buy | C | 0.00 | 571,429 | 0 | 870,357 | 298.9 K to 870.4 K (+191.16 %) |
Nov 10 2016 | ROKA | Roka BioScience, I ... | VALERIANI NICHOLAS J | Director | Option Exercise | C | 0.00 | 50 | 0 | 0 | |
Nov 10 2016 | ROKA | Roka BioScience, I ... | VALERIANI NICHOLAS J | Director | Buy | C | 7.00 | 7,143 | 50,001 | 7,143 | 0 to 7.1 K |
Nov 10 2016 | ROKA | Roka BioScience, I ... | Boesgaard Lars | Vice President, CFO | Option Exercise | C | 0.00 | 25 | 0 | 0 | |
Nov 10 2016 | ROKA | Roka BioScience, I ... | Boesgaard Lars | Vice President, CFO | Buy | C | 7.00 | 3,572 | 25,004 | 8,938 | 5.4 K to 8.9 K (+66.57 %) |
Nov 10 2016 | ROKA | Roka BioScience, I ... | THOMAS PAUL | President and CEO | Option Exercise | C | 0.00 | 50 | 0 | 0 | |
Nov 10 2016 | ROKA | Roka BioScience, I ... | THOMAS PAUL | President and CEO | Buy | C | 7.00 | 7,143 | 50,001 | 85,494 | 78.4 K to 85.5 K (+9.12 %) |
Nov 10 2016 | ROKA | Roka BioScience, I ... | Mary Beth Duseau | SVP, Chief Commerci ... | Option Exercise | C | 0.00 | 10 | 0 | 0 | |
Nov 10 2016 | ROKA | Roka BioScience, I ... | Mary Beth Duseau | SVP, Chief Commerci ... | Buy | C | 7.00 | 1,429 | 10,003 | 1,429 | 0 to 1.4 K |
Oct 31 2016 | ROKA | Roka BioScience, I ... | TPG Group Holdings (SBS) Advis ... | 10% Owner | Option Exercise | P | 0.00 | 571,429 | 0 | 571,429 | |
Oct 31 2016 | ROKA | Roka BioScience, I ... | TPG Group Holdings (SBS) Advis ... | 10% Owner | Option Exercise | P | 0.00 | 4,000 | 0 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Weller Harry R | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Weller Harry R | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | MOTT DAVID M | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | KERINS PATRICK J | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | KERINS PATRICK J | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | BARRIS PETER J | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | BARRIS PETER J | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | P | 0.00 | 53,909 | 0 | 53,909 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | P | 0.00 | 5,660,377 | 0 | 5,660,377 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | P | 0.00 | 38 | 0 | 38 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | P | 0.00 | 3,962 | 0 | 3,962 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Boesgaard Lars | Vice President, CFO | Option Exercise | P | 0.70 | 35,714 | 25,000 | 35,714 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Boesgaard Lars | Vice President, CFO | Option Exercise | P | 0.70 | 25 | 18 | 25 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | VALERIANI NICHOLAS J | Director | Option Exercise | P | 0.70 | 71,429 | 50,000 | 71,429 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | VALERIANI NICHOLAS J | Director | Option Exercise | P | 0.70 | 50 | 35 | 50 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Mary Beth Duseau | SVP, Chief Commerci ... | Option Exercise | P | 0.70 | 14,286 | 10,000 | 14,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Mary Beth Duseau | SVP, Chief Commerci ... | Option Exercise | P | 0.70 | 10 | 7 | 10 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | THOMAS PAUL | President and CEO | Option Exercise | P | 0.70 | 71,429 | 50,000 | 71,429 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | THOMAS PAUL | President and CEO | Option Exercise | P | 0.70 | 50 | 35 | 50 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 53,909 | 0 | 53,909 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 5,660,377 | 0 | 5,660,377 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 38 | 0 | 38 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 3,962 | 0 | 3,962 | |
Jun 24 2016 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jun 24 2016 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jun 24 2016 | ROKA | Roka BioScience, I ... | Cohen Fred E | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jun 24 2016 | ROKA | Roka BioScience, I ... | MCGIRR DAVID W J | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jun 24 2016 | ROKA | Roka BioScience, I ... | Doyle Michael P. | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jun 24 2016 | ROKA | Roka BioScience, I ... | VALERIANI NICHOLAS J | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jan 05 2016 | ROKA | Roka BioScience, I ... | Narajowski Walter M. | Senior VP & General ... | Payment of Exercise | F | 1.23 | 13,738 | 16,898 | 140,571 | 154.3 K to 140.6 K (-8.90 %) |
Jan 05 2016 | ROKA | Roka BioScience, I ... | Mary Beth Duseau | SVP, Chief Commerci ... | Option Exercise | A | 1.13 | 43,000 | 48,590 | 43,000 | |
Jan 05 2016 | ROKA | Roka BioScience, I ... | THOMAS PAUL | President and CEO | Option Exercise | A | 1.13 | 140,000 | 158,200 | 140,000 | |
Jan 05 2016 | ROKA | Roka BioScience, I ... | Boesgaard Lars | Vice President, CFO | Option Exercise | A | 1.13 | 43,000 | 48,590 | 43,000 | |
Dec 07 2015 | ROKA | Roka BioScience, I ... | Boesgaard Lars | Vice President, CFO | Payment of Exercise | F | 1.43 | 128 | 183 | 53,664 | 53.8 K to 53.7 K (-0.24 %) |
Nov 09 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 1.70 | 280 | 476 | 282,672 | 283 K to 282.7 K (-0.10 %) |
Oct 07 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 1.94 | 280 | 543 | 282,952 | 283.2 K to 283 K (-0.10 %) |
Sep 08 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 2.73 | 280 | 764 | 283,232 | 283.5 K to 283.2 K (-0.10 %) |
Aug 13 2015 | ROKA | Roka BioScience, I ... | VALERIANI NICHOLAS J | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
Aug 10 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 2.89 | 280 | 809 | 283,512 | 283.8 K to 283.5 K (-0.10 %) |
Jul 08 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 2.62 | 280 | 734 | 283,792 | 284.1 K to 283.8 K (-0.10 %) |
Jun 26 2015 | ROKA | Roka BioScience, I ... | BARRETT M JAMES | Director | Option Exercise | A | 2.75 | 15,000 | 41,250 | 15,000 | |
Jun 26 2015 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 2.75 | 15,000 | 41,250 | 15,000 | |
Jun 26 2015 | ROKA | Roka BioScience, I ... | Doyle Michael P. | Director | Option Exercise | A | 2.75 | 15,000 | 41,250 | 15,000 | |
Jun 26 2015 | ROKA | Roka BioScience, I ... | MCGIRR DAVID W J | Director | Option Exercise | A | 2.75 | 15,000 | 41,250 | 15,000 | |
Jun 26 2015 | ROKA | Roka BioScience, I ... | Cohen Fred E | Director | Option Exercise | A | 2.75 | 15,000 | 41,250 | 15,000 | |
Jun 09 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 2.52 | 280 | 706 | 284,072 | 284.4 K to 284.1 K (-0.10 %) |
May 08 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 2.91 | 273 | 794 | 284,352 | 284.6 K to 284.4 K (-0.10 %) |
Apr 07 2015 | ROKA | Roka BioScience, I ... | McCardell AmyJo | Senior Vice Preside ... | Payment of Exercise | F | 3.55 | 75 | 266 | 19,702 | 19.8 K to 19.7 K (-0.38 %) |
Apr 07 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 3.55 | 273 | 969 | 284,625 | 284.9 K to 284.6 K (-0.10 %) |
Mar 10 2015 | ROKA | Roka BioScience, I ... | McCardell AmyJo | Senior Vice Preside ... | Payment of Exercise | F | 4.47 | 74 | 331 | 19,777 | 19.9 K to 19.8 K (-0.37 %) |
Mar 10 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 4.47 | 255 | 1,140 | 284,898 | 285.2 K to 284.9 K (-0.09 %) |
Feb 09 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Payment of Exercise | F | 4.50 | 344 | 1,548 | 285,153 | 285.5 K to 285.2 K (-0.12 %) |
Feb 09 2015 | ROKA | Roka BioScience, I ... | McCardell AmyJo | Senior Vice Preside ... | Payment of Exercise | F | 4.50 | 75 | 338 | 19,851 | 19.9 K to 19.9 K (-0.38 %) |
Feb 05 2015 | ROKA | Roka BioScience, I ... | Mary Beth Duseau | SVP, Chief Commerci ... | Option Exercise | A | 3.99 | 104,500 | 416,955 | 104,500 | |
Jan 06 2015 | ROKA | Roka BioScience, I ... | Narajowski Walter M. | Senior VP & General ... | Option Exercise | A | 4.36 | 55,000 | 239,800 | 55,000 | |
Jan 06 2015 | ROKA | Roka BioScience, I ... | Narajowski Walter M. | Senior VP & General ... | Grant | A | 0.00 | 90,000 | 0 | 154,309 | 64.3 K to 154.3 K (+139.95 %) |
Jan 06 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Option Exercise | A | 4.36 | 55,000 | 239,800 | 55,000 | |
Jan 06 2015 | ROKA | Roka BioScience, I ... | SOBIESKI STEVEN | SVP & Chief Financi ... | Grant | A | 0.00 | 90,000 | 0 | 285,497 | 195.5 K to 285.5 K (+46.04 %) |
Jan 06 2015 | ROKA | Roka BioScience, I ... | THOMAS PAUL | President and CEO | Option Exercise | A | 4.36 | 218,500 | 952,660 | 218,500 | |
Nov 17 2014 | ROKA | Roka BioScience, I ... | MCGIRR DAVID W J | Director | Buy | P | 3.65 | 20,994 | 76,697 | 50,000 | 29 K to 50 K (+72.38 %) |
Nov 17 2014 | ROKA | Roka BioScience, I ... | MCGIRR DAVID W J | Director | Buy | P | 3.57 | 29,006 | 103,424 | 29,006 | 0 to 29 K |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 56,490 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 5,931,402 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 80,715 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 8,475,069 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 38,021 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 3,992,203 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 116,981 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 12,283,019 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | P | 12.00 | 3,616 | 43,392 | 30,378 | 26.8 K to 30.4 K (+13.51 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | P | 12.00 | 379,717 | 4,556,604 | 3,190,051 | 2.8 M to 3.2 M (+13.51 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 5,116 | 0 | 26,762 | 21.6 K to 26.8 K (+23.63 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 537,264 | 0 | 2,810,334 | 2.3 M to 2.8 M (+23.64 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 7,563 | 0 | 21,646 | 14.1 K to 21.6 K (+53.70 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 794,178 | 0 | 2,273,070 | 1.5 M to 2.3 M (+53.70 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 3,443 | 0 | 14,083 | 10.6 K to 14.1 K (+32.36 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 361,612 | 0 | 1,478,892 | 1.1 M to 1.5 M (+32.37 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 10,596 | 0 | 10,640 | 44 to 10.6 K (+24,081.82 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 1,112,592 | 0 | 1,117,280 | 4.7 K to 1.1 M (+23,732.76 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 56,490 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 5,931,402 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 80,715 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 8,475,069 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 38,021 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,992,203 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 116,981 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 12,238,019 | 0 | 0 | |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 12.00 | 3,616 | 43,392 | 30,378 | 26.8 K to 30.4 K (+13.51 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 12.00 | 379,717 | 4,556,604 | 3,190,051 | 2.8 M to 3.2 M (+13.51 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 5,116 | 0 | 26,762 | 21.6 K to 26.8 K (+23.63 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 537,264 | 0 | 2,810,334 | 2.3 M to 2.8 M (+23.64 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 7,563 | 0 | 21,646 | 14.1 K to 21.6 K (+53.70 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 794,178 | 0 | 2,273,070 | 1.5 M to 2.3 M (+53.70 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,443 | 0 | 14,083 | 10.6 K to 14.1 K (+32.36 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 361,612 | 0 | 1,478,892 | 1.1 M to 1.5 M (+32.37 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 10,596 | 0 | 10,640 | 44 to 10.6 K (+24,081.82 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,112,592 | 0 | 1,117,280 | 4.7 K to 1.1 M (+23,732.76 %) |
Jul 24 2014 | ROKA | Roka BioScience, I ... | TPG Group Holdings (SBS) Advis ... | 10% Owner | Option Exercise | C | 0.00 | 5,577,814 | 0 | 0 |